drugset / Trial / NCT06560580

Ditefossol Sodium 3% Eye Drops in Patients With Dry Eye

NCT06560580

Completed 97 enrolled Tianjin Eye Hospital
Non-randomizedFactorialOpen-labelTreatment

Summary

This study aimed to evaluate the efficacy of 3% diquafosol sodium eye drops in treating dry eye disease (DED) across different age groups using a propensity score-matched longitudinal design.

Timeline

Start
2021-11-15
Primary completion
2023-07-20
Completion
2024-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Diquafosol Oligonucleotide (other) 3 % Other

Indications